Literature DB >> 30985865

Measuring What Matters in Diabetes.

Rene Rodriguez-Gutierrez1,2, Rozalina G McCoy3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30985865      PMCID： PMC7332201          DOI： 10.1001/jama.2019.4310

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 2.  Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.

Authors:  René Rodríguez-Gutiérrez; Victor M Montori
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-08-23

3.  Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?

Authors:  Kasia J Lipska; Harlan M Krumholz
Journal:  JAMA       Date:  2017-03-14       Impact factor: 56.272

4.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

5.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

6.  Inclusion of Hypoglycemia in Clinical Practice Guidelines and Performance Measures in the Care of Patients With Diabetes.

Authors:  Rene Rodriguez-Gutierrez; Naykky Singh Ospina; Rozalina G McCoy; Kasia J Lipska; Nilay D Shah; Victor M Montori
Journal:  JAMA Intern Med       Date:  2016-11-01       Impact factor: 21.873

7.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

8.  Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum.

Authors:  William T Cefalu; Sanjay Kaul; Hertzel C Gerstein; Rury R Holman; Bernard Zinman; Jay S Skyler; Jennifer B Green; John B Buse; Silvio E Inzucchi; Lawrence A Leiter; Itamar Raz; Julio Rosenstock; Matthew C Riddle
Journal:  Diabetes Care       Date:  2018-01       Impact factor: 19.112
  8 in total
  11 in total

1.  Measuring the Quality of Diabetes Care-Reply.

Authors:  Rozalina G McCoy; Rene Rodriguez-Gutierrez
Journal:  JAMA       Date:  2019-09-24       Impact factor: 56.272

Review 2.  Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes.

Authors:  René Rodríguez-Gutiérrez; Juan Manuel Millan-Alanis; Francisco J Barrera; Rozalina G McCoy
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

3.  Modernizing Diabetes Care Quality Measures.

Authors:  David H Jiang; Patrick J O'Connor; Nathalie Huguet; Sherita Hill Golden; Rozalina G McCoy
Journal:  Health Aff (Millwood)       Date:  2022-06-27       Impact factor: 9.048

Review 4.  Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs.

Authors:  Linda M Hunt; Elisabeth A Arndt; Hannah S Bell; Heather A Howard
Journal:  J Bioeth Inq       Date:  2021-09-06       Impact factor: 2.216

5.  Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals' preferences.

Authors:  Marloes Dankers; Marjorie H J M G Nelissen-Vrancken; Bertien H Hart; Anke C Lambooij; Liset van Dijk; Aukje K Mantel-Teeuwisse
Journal:  Pharmacol Res Perspect       Date:  2021-05

6.  Effect of RG (Coptis root and ginseng) formula in patients with type 2 diabetes mellitus: a study protocol for a randomized controlled and double-blinding trial.

Authors:  Li Jiang; Qiang Fu; Shidong Wang; Yu Chen; Jiayue Li; Yonghua Xiao; Ruixi Sun; Esther Aijia Shen; Junheng Wang; Yaofu Zhang; Zhuang Li; Jiangteng Liu; Xiaozhe Fu; Yuanyuan Liu; Yu Zhao; Guanxun Su; Weijun Huang; Jinxi Zhao
Journal:  Trials       Date:  2022-04-14       Impact factor: 2.279

7.  Development and evaluation of a patient-centered quality indicator for the appropriateness of type 2 diabetes management.

Authors:  Rozalina G McCoy; Kasia J Lipska; Holly K Van Houten; Nilay D Shah
Journal:  BMJ Open Diabetes Res Care       Date:  2020-11

8.  Values informing the development of an indicator of appropriate diabetes therapy: qualitative study.

Authors:  Christina M LaVecchia; Victor M Montori; Nilay D Shah; Rozalina G McCoy
Journal:  BMJ Open       Date:  2020-12-02       Impact factor: 2.692

9.  Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program.

Authors:  Tamara K Young; Jing-Wei Li; Amy Kang; Hiddo J L Heerspink; Carinna Hockham; Clare Arnott; Brendon L Neuen; Sophia Zoungas; Kenneth W Mahaffey; Vlado Perkovic; Dick de Zeeuw; Greg Fulcher; Bruce Neal; Meg Jardine
Journal:  Diabetologia       Date:  2021-08-26       Impact factor: 10.122

10.  Global trend of diabetes mortality attributed to vascular complications, 2000-2016.

Authors:  Wei Ling; Yi Huang; Yan-Mei Huang; Rong-Rong Fan; Yi Sui; Hai-Lu Zhao
Journal:  Cardiovasc Diabetol       Date:  2020-10-20       Impact factor: 9.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.